BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2016
View Archived Issues
Heptares updates on muscarinic M1 receptor agonist programs for cognitive impairment
Read More
Enrollment begins in phase Ib study of CV-MG01 in myasthenia gravis
Read More
FDA grants orphan drug designation to eltoprazine
Read More
Cidara Therapeutics's CD101 IV wins FDA orphan drug status
Read More
Cocrystal inlicenses CRISPR/Cas9 technologies
Read More
Synlogic and AbbVie enter IBD collaboration
Read More
AbbVie reports topline results from phase III elagolix trial in endometriosis
Read More
FDA lifts partial clinical hold on vesigenurtucel-L
Read More
UCB and Baylor College of Medicine enter strategic neurodegeneration research alliance
Read More
Lundbeck recaps progress of fourth quarter 2015
Read More
Astellas Pharma completes tender offer for Ocata Therapeutics
Read More
SymBio and Teikyo Heisei University collaborate to develop TTR1 therapeutic anticancer drug
Read More
Patient with B-cell lymphoma in remission following treatment with OXS-1550
Read More
Shanghai Allist Pharmaceutical presents EGFR inhibitors
Read More
Innov17 patents retinoid-related orphan receptor ligands
Read More
February 12: Thomson Reuters Drug News Publication Holiday
Read More
GlaxoSmithKline introduces Lp-PLA2 inhibitors
Read More
Boehringer Ingelheim Pharma divulges cytochrome P450 inhibitors
Read More
Beta Pharma patent describes CDK4 and 6 inhibitors
Read More
Almirall completes acquisition of ThermiGen
Read More
Biogen launches USD 20 million challenge for Target ALS
Read More
FDA accepts KP-201/APAP NDA, grants priority review
Read More
Small peptide IL-1beta receptor antagonist from Serodus delays diabetes onset in vivo
Read More
Somatostatin sst2 receptor antagonist ameliorates hypoglycemia after recurrent hypoglycemic events
Read More
Resolve Therapeutics reports positive data from SLE study
Read More
TransCelerate BioPharma launches BioCelerate subsidiary
Read More
Mylan makes offer to acquire Meda
Read More